PerCP anti-mouse CD45 Antibody

Product Details

Verified Reactivity

Mouse

Antibody Type

Monoclonal

Host Species

Rat

Immunogen

Mouse thymus or spleen

Formulation

Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.

Preparation

The antibody was purified by affinity chromatography, and conjugated with PerCP under optimal conditions.

Concentration

0.2 mg/ml

Storage & Handling

The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.

Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 10⁶ cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

* PerCP has a maximum absorption of 482 nm and a maximum emission of 675 nm.

Excitation Laser

Blue Laser (488 nm)

Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation³, complement-dependent cytotoxicity^1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)^4,6, Western blotting⁷, and spatial biology (IBEX)^10,11. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Application References

(PubMed link indicates BioLegend citation)

1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
8. Liu F, et al. 2012. Blood. 119:3295. PubMed
9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
10. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
11. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed

Product Citations

1. Quispe Calla N, et al. 2016. Sci Rep. 6:37723. PubMed
2. Filipello F et al. 2018. Immunity. 48(5):979-991 . PubMed
3. Haratani K, et al. 2019. J Clin Invest. 130:374. PubMed
4. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
5. Schädlich IS, et al. 2022. iScience. 25:104470. PubMed
6. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
7. Sun J, et al. 2020. Acta Biomater. 289:106. PubMed
8. Shin J, et al. 2016. Sci Rep. 6:23426. PubMed
9. Bo Yu et al. 2018. Cell stem cell. 23(2):193-209 . PubMed
10. Keeter WC, et al. 2022. Eur Heart J Open. 2:oeac028. PubMed
11. Di Martile M, et al. 2020. J Immunother Cancer. 8:. PubMed
12. Zhou J, et al. 2021. Int J Med Sci. 18:3516. PubMed
13. Lopez-Guadamillas E, et al. 2016. Sci Rep. 6:34542. PubMed
14. Kawashima N, et al. 2022. Nat Commun. 13:1624. PubMed
15. Lin H, et al. 2020. Front Microbiol. 1.330555556. PubMed
16. Stolp B, et al. 2022. Cell Rep. 38:110387. PubMed
17. Tilstam PV, et al. 2021. J Clin Invest. 131:. PubMed
18. Tajfirouz D, et al. 2017. Virology. 10.1016/j.virol.2017.02.022. PubMed
19. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
20. Enriquez AB, et al. 2022. iScience. 25:104305. PubMed
21. Zhou HF, et al. 2022. Front Pharmacol. 13:778755. PubMed
22. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
23. Royzman D, et al. 2022. Front Immunol. 13:1012647. PubMed
24. Ayasoufi K, et al. 2020. Brain. 3629:143. PubMed
25. Peng L, et al. 2020. Transl Lung Cancer Res. 0.892361111. PubMed
26. Liu YJ, et al. 2020. Theranostics. 10:5225. PubMed
27. Nguyen CM, et al. 2019. Diabetes. 68:1499. PubMed
28. Zhang C, et al. 2021. Clin Transl Immunology. 10:e1310. PubMed
29. She L, et al. 2021. JCI Insight. 6:e143509. PubMed
30. Lee M, et al. 2014. PLoS One. 9:112666. PubMed
31. Gabbita S, et al. 2015. PLoS One. 10: e0137305. PubMed
32. Enriquez AB, et al. 2022. iScience. 25:104305. PubMed
33. Law HL, et al. 2020. Front Pharmacol. 11:274. PubMed
34. Sears SM, et al. 2020. Am J Physiol Renal Physiol. 319:F674. PubMed
35. Taube C, et al. 2011. PLoS One. 6:e21799. PubMed
36. Yang S, et al. 2019. Nat Commun. 10:2782. PubMed
37. Fatkhullina AR et al. 2018. Immunity. 49(5):943-957 . PubMed
38. Ngamsri KC, et al. 2021. Int J Mol Sci. 22:. PubMed
39. Amo-Aparicio J, et al. 2021. Theranostics. 11:9805. PubMed
40. Saitoh BY, et al. 2021. Brain Behav Immun. 95:362. PubMed
41. Aebischer D, et al. 2014. PLoS One. 9:99297. PubMed
42. Everard A, et al. 2014. Nat Commun. 5:5648. PubMed
43. Hrdinka M, et al. 2016. PLoS One. 11: 0162863. PubMed
44. Demandt JAF, et al. 2021. Frontiers in Cell and Developmental Biology. 9:664258. PubMed
45. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
46. Kumaran Satyanarayanan S, et al. 2019. Nat Commun. 10:3471. PubMed
47. Zou J, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:983. PubMed
48. Mulas F, et al. 2020. Cell Mol Immunol. . PubMed
49. Mulder K, et al. 2021. Immunity. 54(8):1883-1900.e5. PubMed
50. Osaka M, et al. 2016. Sci Rep. 6:21391. PubMed
51. Davis M, et al. 2015. J Immunol. 194:2219. PubMed
52. West D, et al. 2014. J Immunol. 192:1762. PubMed
53. Wang F, et al. 2019. Cell Death Dis. 1.036111111. PubMed
54. Dmitrieva‐Posocco O et al. 2019. Immunity. 50(1):166-180 . PubMed
55. Arcangeli S, et al. 2022. J Clin Invest. 132: . PubMed
56. Wang X, et al. 2018. Cell Death Dis. 9:578. PubMed
57. Oldrini B, et al. 2018. Nat Commun. 9:1466. PubMed
58. Xiong X et al. 2019. Mol Cell. 75(3):644-660 . PubMed
59. She L, et al. 2019. J Immunol. 203:2520. PubMed
60. Zhu Y, et al. 2021. EMBO J. 40:e105320. PubMed
61. Sefik E, et al. 2021. Nat Biotechnol. . PubMed
62. Wells KL, et al. 2020. Elife. 9:. PubMed
63. Voss M, et al. 2015. Am J Physiol Lung Cell Mol Physiol. 309: L188 - L195. PubMed
64. Choi EW, et al. 2020. Sci Rep. 10:12001. PubMed
65. Rangaraju S, et al. 2018. Mol Neurodegener. 13:24. PubMed
66. Bogie JFJ, et al. 2021. J Autoimmun. 124:102723. PubMed
67. Kovacs M, et al. 2021. Acta Neuropathol Commun. 9:136. PubMed
68. Lü X, et al. 2021. Exp Ther Med. 22:1005. PubMed
69. Wang X, et al. 2020. Nat Commun. 4.505555556. PubMed
70. Peñaloza HF, et al. 2018. Biochem Biophys Rep. 13:12. PubMed
71. Chulpanova DS, et al. 2021. Biology (Basel). 10:. PubMed
72. Taddio MF, et al. 2021. Mol Imaging Biol. 23:196. PubMed
73. Blanchard L, et al. 2022. STAR Protoc. 3:101444. PubMed
74. Woods S, et al. 2015. Am J Physiol Lung Cell Mol Physiol. 308:912. PubMed
75. Baomei Wang et al. 2019. Cell reports. 26(6):1614-1626 . PubMed
76. Zhang S, et al. 2022. Nat Commun. 13:4744. PubMed
77. Li X, et al. 2021. Cell Death Dis. 12:314. PubMed
78. Gorina R, et al. 2014. J Immunol. 192:324. PubMed
79. Kerkhofs D, et al. 2020. Theranostics. 7.022222222. PubMed
80. Yamamuro T, et al. 2020. Nat Commun. 3.340277778. PubMed
81. Gomzikova MO, et al. 2020. Pharmaceutics. 12:00. PubMed
82. Enam S, et al. 2017. Biomaterials. 10.1016/j.biomaterials.2017.07.013. PubMed
83. Zhao Y, et al. 2020. Immunity. 51(6):1059-1073.e9.. PubMed
84. Doni A, et al. 2021. Nat Commun. 12:3739. PubMed
85. Cartwright ANR, et al. 2021. Cancer Immunol Res. 9:470. PubMed
86. Yamasaki R, et al. 2014. J Exp Med. 211:1533. PubMed
87. Wong L, et al. 2013. J Biol Chem. 288:35170. PubMed
88. Yin X, et al. 2015. J Immunol. 194:4029. PubMed
89. SL C, et al. 2016. JCI Insight. 1: 83116. PubMed
90. Cao Z, et al. 2021. Molecular Cell. 81(17):3604-3622.e10. PubMed
91. Westrich JA, et al. 2019. Oncogene. 38:7166. PubMed
92. Liu Q, et al. 2021. Adv Mater. 33:e2102852. PubMed
93. Sears SM, et al. 2022. Kidney360. 3:818. PubMed
94. Zukauskas A, et al. 2018. mSphere. 3:e00303. PubMed
95. Bai C, et al. 2022. Exp Ther Med. 24:673. PubMed
96. Jaeger N, et al. 2020. Cell Rep. 33:108331. PubMed
97. Chen R, et al. 2019. Mol Med Rep. 1.172916667. PubMed
98. Wang X, et al. 2021. Sci Transl Med. 13:. PubMed
99. Akhand SS, et al. 2020. Cancer Immunol Res. 8:1542. PubMed
100. Buschor S, et al. 2017. PLoS Pathogens. 13(6):e1006476. PubMed
101. Chuang LT, et al. 2021. Molecules. 26:. PubMed

RRID

AB_893343 (BioLegend Cat. No. 103129)
AB_893339 (BioLegend Cat. No. 103130)

Antigen Details

Structure

Protein tyrosine phosphatase (PTP) family, 180-240 kD

Distribution

All hematopoietic cells except mature erythrocytes and platelets

Function

Phosphatase, T and B cell activation

Ligand/Receptor

Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1

Cell Type

B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs

Biology Area

Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells

Molecular Family

CD Molecules

Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID

19264 View all products for this Gene ID

UniProt

View information about CD45 on UniProt.org

Documentation

• Technical data sheet
• Certificate of Analysis
• Material Safety Data Sheet

Reviews

Related Protocols

• Cell Surface Flow Cytometry Staining Protocol

Related Pages & Pathways

Related FAQs

How stable is PerCP/Cy5.5 tandem as compared to PerCP alone?

PerCP/Cy5.5 is quite photostable and also better than PerCP alone in withstanding fixation.

Other Formats

Certificate of Analysis